Accredo To Pay $60M In Novartis Exjade Kickback Suit
By Kurt Orzeck · May 1, 2015, 9:40 PM EDT
Specialty pharmacy Accredo Health Group Inc. will pay $14.9 million to resolve state regulators' claims it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp., U.S. Attorney Preet Bharara...
To view the full article, register now.